Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · Real-Time Price · USD

39.49

+2.50 (6.76%)

At close: Apr 2, 2026, 4:00 PM EDT

39.60

+0.11 (0.28%)

After-hours: Apr 2, 2026, 7:59 PM EDT

Soleno Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	70.11	87.93	169.68	14.6	21.3
Short-Term Investments	235.37	203.51	-	-	-
Cash & Short-Term Investments	305.47	291.44	169.68	14.6	21.3
Cash Growth	4.82%	71.76%	1062.04%	-31.46%	-56.72%
Accounts Receivable	28.21	-	-	-	-
Inventory	15.02	-	-	-	-
Other Current Assets	7.11	2.45	1.68	1.05	1.12
Total Current Assets	355.81	293.89	171.36	15.65	22.42
Net Property, Plant & Equipment	2.38	2.98	0.42	0.16	0.45
Other Intangible Assets	4.86	6.81	8.75	10.69	12.64
Long-Term Investments	200.62	27.21	-	-	-
Other Long-Term Assets	0.16	0.08	0.17	-	0.04
Total Assets	563.83	330.97	180.69	26.5	35.55
Accounts Payable	12.44	8.88	3.15	1.78	3.25
Accrued Expenses	9.68	4.78	6.53	4.9	4.15
Current Portion of Leases	0.73	0.53	0.27	0.16	0.28
Other Current Liabilities	38.53	4.56	1.56	0.48	0.32
Total Current Liabilities	61.36	18.75	11.51	7.31	8.01
Long-Term Debt	49.86	49.83	-	-	-
Long-Term Leases	1.96	2.47	0.13	-	0.18
Other Long-Term Liabilities	0.53	14.81	11.55	8.84	9.58
Total Long-Term Liabilities	52.35	67.11	11.68	8.84	9.75
Total Liabilities	113.72	85.86	23.18	16.15	17.76
Common Stock	0.05	0.05	0.03	0.01	0.08
Additional Paid-in Capital	881.02	696.97	433.89	247.76	231.07
Accumulated Other Comprehensive Income	0.42	0.36	-	-	-
Retained Earnings	-431.37	-452.26	-276.41	-237.42	-213.36
Shareholders' Equity	450.12	245.11	157.51	10.35	17.79
Total Liabilities & Equity	563.83	330.97	180.69	26.5	35.55
Total Debt	52.55	52.83	0.4	0.16	0.46
Net Cash (Debt)	252.92	238.61	169.28	14.45	20.85
Net Cash Growth	6.00%	40.96%	1071.72%	-30.70%	-57.53%
Net Cash Per Share	4.83	5.94	10.26	1.72	3.92
Book Value	450.12	245.11	157.51	10.35	17.79
Book Value Per Share	8.59	6.10	9.55	1.23	3.35
Tangible Book Value	445.25	238.31	148.76	-0.35	5.16
Tangible Book Value Per Share	8.50	5.93	9.02	-0.04	0.97

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q